728 filings
ARS
2023 FY
ARMP
Armata Pharmaceuticals Inc
29 Apr 24
Annual report to shareholders
5:03pm
DEF 14A
ARMP
Armata Pharmaceuticals Inc
Definitive proxy
29 Apr 24
5:02pm
8-K
ARMP
Armata Pharmaceuticals Inc
22 Mar 24
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
8:00am
10-K
2023 FY
ARMP
Armata Pharmaceuticals Inc
Annual report
21 Mar 24
4:20pm
8-K
ARMP
Armata Pharmaceuticals Inc
21 Mar 24
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2023 Results and Provides Corporate Update
4:15pm
8-K
x389rpi lwh4ockcv
4 Mar 24
Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva
4:03pm
S-8
3boosx
23 Jan 24
Registration of securities for employees
4:17pm
S-8
6gxn68g4iyn7z0r44js
15 Nov 23
Registration of securities for employees
5:24pm
8-K
6dv9hyj08x 2wvn
14 Nov 23
Armata Pharmaceuticals Announces Third Quarter 2023 Results and Provides Corporate Update
12:00am
UPLOAD
o7nwr5w1m0 s4pg7wat
13 Nov 23
Letter from SEC
12:00am
CORRESP
fsymto82bvjgnk
7 Nov 23
Correspondence with SEC
12:00am
UPLOAD
tozln8uuopb9
26 Oct 23
Letter from SEC
12:00am
8-K
0zlu5j366b05z
20 Sep 23
Departure of Directors or Certain Officers
8:00am
8-K
5c6g0w2v4v
14 Aug 23
Armata Pharmaceuticals Announces Second Quarter 2023 Results and Provides Corporate Update
7:15am
ARS
mfsc5ad
3 Aug 23
Annual report to shareholders
4:37pm
DEFA14A
s07jbk5fizpj6
3 Aug 23
Additional proxy soliciting materials
4:35pm